Hospira (HSP +7.2%) shares power ahead after the specialty pharmaceutical company's Q4 adjusted...


Hospira (HSP +7.2%) shares power ahead after the specialty pharmaceutical company's Q4 adjusted EPS from ongoing operations came in at $0.51 and revenues hit $1.01B, both topping expectations. CEO Michael Ball says a factory cited for manufacturing problems had reopened and was nearing previous production levels.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs